DOP2002000331A - PPAR COMPOUND - Google Patents
PPAR COMPOUNDInfo
- Publication number
- DOP2002000331A DOP2002000331A DO2002000331A DO2002000331A DOP2002000331A DO P2002000331 A DOP2002000331 A DO P2002000331A DO 2002000331 A DO2002000331 A DO 2002000331A DO 2002000331 A DO2002000331 A DO 2002000331A DO P2002000331 A DOP2002000331 A DO P2002000331A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- cholesterol
- levels
- triglycerides
- compounds
- ldl
- Prior art date
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 6
- 235000012000 cholesterol Nutrition 0.000 abstract 3
- 102000015779 HDL Lipoproteins Human genes 0.000 abstract 2
- 108010010234 HDL Lipoproteins Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- 150000003626 triacylglycerols Chemical class 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 238000008214 LDL Cholesterol Methods 0.000 abstract 1
- 102000007330 LDL Lipoproteins Human genes 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 102000023984 PPAR alpha Human genes 0.000 abstract 1
- 108010028924 PPAR alpha Proteins 0.000 abstract 1
- 239000012190 activator Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Activadores de PPAR alfa, composiciones farmacéuticas que contienen tales compuestos y el uso de tales compuestos para elevar ciertos niveles de lípidos en plasma, incluyendo el colesterol asociado a lipoproteínas de alta densidad, y para reducir otros niveles de lípidos en plasma, tales como el colesterol asociado a LDL y los triglicéridos y, por consiguiente, para tratar enfermedades que están exacerbadas por bajos niveles de colesterol HDL y/o altos niveles de colesterol LDL y triglicéridos, tales como la aterosclerosis y Enfermedades cardiovasculares en mamíferos, incluyendo los scres humanos.PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to raise certain levels of plasma lipids, including high density lipoprotein-associated cholesterol, and to reduce other plasma lipid levels, such as cholesterol associated with LDL and triglycerides and, therefore, to treat diseases that are exacerbated by low levels of HDL cholesterol and / or high levels of LDL cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in mammals, including human scres.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DO2002000331A DOP2002000331A (en) | 2002-01-23 | 2002-01-23 | PPAR COMPOUND |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DO2002000331A DOP2002000331A (en) | 2002-01-23 | 2002-01-23 | PPAR COMPOUND |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2002000331A true DOP2002000331A (en) | 2003-03-15 |
Family
ID=44261059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2002000331A DOP2002000331A (en) | 2002-01-23 | 2002-01-23 | PPAR COMPOUND |
Country Status (1)
| Country | Link |
|---|---|
| DO (1) | DOP2002000331A (en) |
-
2002
- 2002-01-23 DO DO2002000331A patent/DOP2002000331A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28097A1 (en) | PPAR ACTIVATORS | |
| CR9089A (en) | COMPOUNDS AND DERIVATIVES OF DIBENCIL AMINA | |
| UY28243A1 (en) | QUINOLINE AND QUNOXALINE COMPOUNDS | |
| UY30197A1 (en) | DIBENCILAMINE COMPOUNDS AND DERIVATIVES | |
| CR6310A (en) | 1,2,3,4-TETRAHYDROQUINOLINS 2-SUBSTITUTED 4-CARBOXYAMIN REPLACED | |
| BR0207285A (en) | Ppar agonists | |
| PA8539101A1 (en) | PPAR COMPOUNDS | |
| CR8881A (en) | HETEROARIL- AND PHENYLSULFAMOIL SUBSTITUTED COMPOUNDS | |
| BRPI0410479A (en) | tetrahydroisoquinoline derivatives as activators of ppar- (alpha) | |
| ECSP066834A (en) | HETEROARIL- AND FENILSULFAMOIL SUBSTITUTED COMPOUNDS | |
| CR9012A (en) | 4-AMINO-SUBSTITUTED-2-SUBSTITUTED-1,2,3,4-TETRAHYDROQUINOLINE COMPOUNDS | |
| ECSP088729A (en) | DIBENCILAMINE COMPOUNDS AND DERIVATIVES | |
| DOP2002000331A (en) | PPAR COMPOUND | |
| UY29124A1 (en) | QUINOLINE COMPOUNDS | |
| UY27158A1 (en) | PPAR COMPOUNDS | |
| UY27168A1 (en) | PPAR AGONISTS | |
| DOP2002000327A (en) | PPAR AGONISTS | |
| DOP2003000762A (en) | PPAR ACTIVATORS | |
| DOP2005000179A (en) | QUINOLINE COMPOUND | |
| CR8567A (en) | HETEROARIL-Y FENILSULFAMOILO SUBSTITUTED COMPOUNDS | |
| DOP2005000238A (en) | COMPOUNDS AND DERIVATIVES OF DIBENCIL AMINA | |
| PA8589501A1 (en) | PPAR ACTIVATORS | |
| ECSP088730A (en) | DIBENCILAMINE DERIVATIVES AS CETP INHIBITORS | |
| CU20080164A7 (en) | DIBENCILAMINE COMPOUNDS AND DERIVATIVES | |
| ECSP993134A (en) | 1,2,3,4- TETRAHIDROQUINOLINAS -2-SUBSTITUTED 4- CARBOXIAMINO SUBSTITUTED |